Scalper1 News
Big-cap biotech Amgen (AMGN) beat Wall Street’s third-quarter estimates and guided full-year earnings a bit above consensus Monday, sending its recently hot stock up 1% in after-hours trading. Amgen’s earnings excluding one-time items rose 19% over the year-ago quarter to $2.30 a share, beating analysts’ consensus by 19 cents, according to Thomson Reuters. Sales increased 6% to $5.03 billion, about $70 million ahead of estimates. On the conference Scalper1 News
Scalper1 News